Skip to content
Disclosery

VHCP Management, LLC

Follow

13F filer, CIK 1479355, NEW YORK, NY

VHCP Management, LLC reported $115,177,000 across 23 holdings for the quarter ended 2016-03-31, in a 13F-HR filed 2016-05-13. Its ten largest share positions make up 85.74% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-16-017146

Period
2016-03-31
Reported value
$115M
Holdings
23
Top 10 weight
85.74%
New
3
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AXOVANT SCIENCES LTDnew+184,110$2.11M
BCRXnew+562,943$1.59M
ONCnew+51,000$1.5M
ZAFGEN INCadded+60,634$405K
OCERA THERAPEUTICS INC COMadded+92,820$273K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
GW PHARMACEUTICALS PLCexited-311,853-$21.7M
DBV Technologiesreduced-6,750-$429K
CTMXreduced-10,800-$139K
Sierra Oncology, Inc.reduced-18,944-$128K
Cynapsus Therapeutics Increduced-1,651-$20K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2016

Share positions as resolved from 13F-HR 0000950123-16-017146, largest first. % of portfolio is the value over $115,177,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DBV TechnologiesDBV TechnologiesQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 693,810 shares; 2015Q2: 693,810 shares; 2015Q3: 693,810 shares; 2015Q4: 463,643 shares; 2016Q1: 456,893 shares 456,893$29M25.19%-6,750
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,095,734 shares; 2015Q2: 1,095,734 shares; 2015Q3: 1,095,734 shares; 2015Q4: 1,095,734 shares; 2016Q1: 1,095,734 shares 1,095,734$20.8M18.07%0Timeline
CHRSCOHERUS ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 870,269 shares; 2015Q2: 870,269 shares; 2015Q3: 870,269 shares; 2015Q4: 611,010 shares; 2016Q1: 611,010 shares 611,010$13M11.26%0Timeline
LIPOCINE INC NEWLIPOCINE INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 669,921 shares; 2015Q2: 1,269,921 shares; 2015Q3: 1,269,921 shares; 2015Q4: 849,921 shares; 2016Q1: 849,921 shares 849,921$8.63M7.49%0
ANACOR PHARMACEUTICALS INCANACOR PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,178,474 shares; 2015Q2: 1,178,474 shares; 2015Q3: 1,178,474 shares; 2015Q4: 140,756 shares; 2016Q1: 140,756 shares 140,756$7.52M6.53%0
AVALANCHE BIOTAVALANCHE BIOTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,382,735 shares; 2015Q2: 1,382,735 shares; 2015Q3: 1,382,735 shares; 2015Q4: 1,102,735 shares; 2016Q1: 1,102,735 shares 1,102,735$5.7M4.95%0
FLAMEL TECHNOLOGIES-SP ADRFLAMEL TECHNOLOGIES-SP ADRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 500,000 shares; 2015Q2: 500,000 shares; 2015Q3: 500,000 shares; 2015Q4: 500,000 shares; 2016Q1: 500,000 shares 500,000$5.52M4.79%0
ZAFGEN INCZAFGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 541,480 shares; 2015Q2: 541,480 shares; 2015Q3: 541,480 shares; 2015Q4: 541,480 shares; 2016Q1: 602,114 shares 602,114$4.02M3.49%+60,634
OCERA THERAPEUTICS INC COMOCERA THERAPEUTICS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 703,730 shares; 2015Q2: 703,730 shares; 2015Q3: 703,730 shares; 2015Q4: 703,730 shares; 2016Q1: 796,550 shares 796,550$2.34M2.03%+92,820
AKARI THERAPEUTICS PLCAKARI THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 527,842 shares; 2015Q4: 158,352 shares; 2016Q1: 158,352 shares 158,352$2.22M1.92%0
AXOVANT SCIENCES LTDAXOVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: 184,110 shares 184,110$2.11M1.84%new
Alcobra LtdAlcobra LtdQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,500,000 shares; 2015Q2: 1,500,000 shares; 2015Q3: 1,500,000 shares; 2015Q4: 484,500 shares; 2016Q1: 484,500 shares 484,500$1.84M1.59%0
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 811,152 shares; 2015Q2: 811,152 shares; 2015Q3: 811,152 shares; 2015Q4: 90,000 shares; 2016Q1: 90,000 shares 90,000$1.67M1.45%0Timeline
ARCA biopharma IncARCA biopharma IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: 10,789,324 shares; 2015Q3: 1,541,331 shares; 2015Q4: 462,399 shares; 2016Q1: 462,399 shares 462,399$1.6M1.39%0
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 1,744,356 shares; 2015Q2: 373,686 shares; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: 562,943 shares 562,943$1.59M1.38%newTimeline
ONCBEONE MEDICINES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: not reported; 2016Q1: 51,000 shares 51,000$1.5M1.3%newTimeline
Cynapsus Therapeutics IncCynapsus Therapeutics IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 5,878,855 shares; 2015Q2: 367,427 shares; 2015Q3: 367,427 shares; 2015Q4: 110,226 shares; 2016Q1: 108,575 shares 108,575$1.32M1.14%-1,651
EDGE THERAPEUTICS INCEDGE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: 135,000 shares; 2016Q1: 135,000 shares 135,000$1.24M1.07%0
GLOBAL BLOOD THERAPEUTICS U…GLOBAL BLOOD THERAPEUTICS USDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: 60,691 shares; 2016Q1: 72,990 shares 72,990$1.16M1.01%+12,299
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: not reported; 2015Q4: 75,000 shares; 2016Q1: 64,200 shares 64,200$828K0.72%-10,800Timeline
STEMLINE THERAPEUTICS INCSTEMLINE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: 451,400 shares; 2015Q2: 451,400 shares; 2015Q3: 451,400 shares; 2015Q4: 135,420 shares; 2016Q1: 135,420 shares 135,420$631K0.55%0
RGNXREGENXBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 1,083,454 shares; 2015Q4: 52,500 shares; 2016Q1: 52,500 shares 52,500$567K0.49%0Timeline
Sierra Oncology, Inc.Sierra Oncology, Inc.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2014Q2: restricted; 2014Q3: restricted; 2014Q4: restricted; 2015Q1: not reported; 2015Q2: not reported; 2015Q3: 250,000 shares; 2015Q4: 75,000 shares; 2016Q1: 56,056 shares 56,056$378K0.33%-18,944

Sold out in Q1 2016

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
GW PHARMACEUTICALS PLCGW PHARMACEUTICALS PLC311,853$21.7Mshares

How Q1 2016 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-16-017146 base2016-05-13acceptance time not in the bulk data set